Zobrazeno 1 - 10
of 13
pro vyhledávání: '"T. W. Kragstrup"'
Publikováno v:
BMC Rheumatology, Vol 2, Iss 1, Pp 1-10 (2018)
Abstract Background Resveratrol is a natural polyphenol found in berries, roots and wine that is well known to have anti-inflammatory and anti-oxidative properties. The anti-inflammatory effect has been reported for both immune cells and connective t
Externí odkaz:
https://doaj.org/article/856e72b2f7c3480cbef4401e79b7c9a5
Publikováno v:
12.01 - Idiopathic interstitial pneumonias.
Autor:
L. Skaarup, T. W. Kragstrup
Publikováno v:
Annals of the Rheumatic Diseases. 81:1820.2-1820
BackgroundThe list of biological DMARDs (bDMARDS) and targeted synthetic DMARDs (tsDMARDs) approved to treat synovitis and extra-articular manifestations is long and constantly expanding. The choice of drug for the individual patient depends on multi
Autor:
S. Khatri, J. Hansen, N. Pedersen, S. Gram-Nielsen, A. Mendes, I. Chronakis, U. Keiding, B. Réthi, M. H. Clausen, T. W. Kragstrup, K. Astakhova
Publikováno v:
Annals of the Rheumatic Diseases. 81:466.1-466
BackgroundAnti-citrullinated peptide antibodies (ACPA) appear 10–15 years before the diagnosis of rheumatoid arthritis (RA) and are associated with a more severe disease course. In previous work, we rationally designed and screened ACPA-binding pep
Autor:
M. A. Nielsen, D. Køster, K. Stengaard-Pedersen, P. Busson, P. Junker, K. Hørslev-Petersen, M. L. Hetland, M. Østergaard, M. Hvid, T. W. Kragstrup, B. Deleuran
Publikováno v:
Annals of the Rheumatic Diseases. 81:462.1-463
BackgroundFibroblast-like synoviocytes (FLS) are pivotal mediators of rheumatoid synovitis expansive growth and invasiveness which respond insufficiently to disease-modifying antirheumatic drugs. Galectin-9 (Gal-9) is a lectin with well-conserved car
Autor:
S. Lomholt, T. W. Kragstrup
Publikováno v:
Annals of the Rheumatic Diseases. 81:465.1-465
BackgroundSynovial fibroblasts are key players in the disease pathology of rheumatoid arthritis and specific fibroblast subsets have been linked to joint inflammation and joint destruction[1]. These synovial fibroblasts can be cultured from both the
Publikováno v:
Annals of the Rheumatic Diseases. 81:392.1-392
BackgroundImmune-mediated inflammatory arthritis (IMIA) is a group of diseases characterized by chronic synovitis including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondyloarthritis (SpA). Some disease modifying antirheumatic drugs
Publikováno v:
Annals of the Rheumatic Diseases. 81:1183.1-1183
BackgroundInflammatory arthritis and enthesitis has been documented as adverse events in patients with atopic dermatitis treated with dupilumab targeting the interleukin 4 (IL-4) receptor alpha subunit (1,2). The disease mechanisms underlying atopic
Publikováno v:
Annals of the Rheumatic Diseases. 81:234.1-234
BackgroundJanus kinase inhibitors (JAKi) have been associated with an increased risk of venous thromboembolism (VTE) [1]. VTE comprises deep vein thrombosis and pulmonary embolism and is associated with complications such as recurrent VTE, post throm
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 21:749-757
The extracellular matrix (ECM) of skeletal muscle is critical for force transmission and for the passive elastic response of skeletal muscle. Structural, biochemical, cellular, and functional changes in skeletal muscle ECM contribute to the deteriora